Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Femasys, Hemovent, Masimo, Neuspera, Rapidai, Syantra.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 2seventy, Abbvie, Affamed, Bristol Myers Squibb, Candel, Hanchorbio, Intelgenx, Lundbeck, Novo Nordisk, Otsuka.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvotech, Eli Lilly, Horizon, Ips, Minghui, Nicox, NS, Ocumension, Pfizer, Soligenix.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Clearpoint Neuro.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allegro, Astrazeneca, Atma, Aviceda, Fusion, Merck & Co., Sab.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Genetesis.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Covis, Junshi, Kala, Oncolyze.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avation Medical, Magnolia Medical, Nova Eye Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acurx, Biosyngen, Boan, Bone, HRA, Nova Mentis, Regenxbio, Sarepta, Takeda, Telix, Vertex.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Moximed, R2 Technologies, Reach Neuro.